Generative AI medical device rules start with two questions
The FDA expects draft guidance on generative AI devices within months. Its framework asks how independently a tool acts and how much harm a wrong answer could do.
Read article
The FDA expects draft guidance on generative AI devices within months. Its framework asks how independently a tool acts and how much harm a wrong answer could do.
Read articleAgent Skills now has a neutral home at the Linux Foundation. The format matters less than what teams put in it: written procedures that people and agents can both check.
Developers are handing AI more of the coding, from tests to application logic, but most still keep code review and debugging. That makes written-down intent matter more.
Small businesses are building AI faster than they can track it: 35% found unapproved AI and 49% got a surprise bill. Small business AI governance can start with a one-page list.
Inova went from one AI review a month to more than twelve. Most of that AI arrives as vendor features, which is why a health system AI inventory, an owner per feature and staff training matter.
Prompt injection can't be patched out of AI agents. The October 2026 evidence points to a plainer fix: limit what each agent can read, change and send, and keep humans on the risky actions.
AI makes coding faster, but two 2026 developer surveys show friction hasn't dropped. The bottlenecks are context, requirements and review, and few teams have a clear AI strategy.
AI local search grew from 9% to 52% of consumers in a year, but most people verify what the AI says. Consistent, plain facts matter more than chasing a ranking.
Approving an AI tool is only the start. Health systems are finding unknown AI, quiet model swaps and uneven local testing, and building habits to keep watch.
October brought a wave of large open-weight models. Before picking one, look at the license, the hardware it needs and how it does on your own tasks.